We are live on ! Find out more
E

Ergoteles Portfolio holdings

AUM $68.2M
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+7.33%
1 Year Est. Return
+36.16%
3 Year Est. Return
+76.43%
5 Year Est. Return
10 Year Est. Return
AUM
$4.36B
AUM Growth
+$1.15B
Cap. Flow
+$991M
Cap. Flow %
22.7%
Top 10 Hldgs %
14.65%
Holding
1,807
New
1,048
Increased
148
Reduced
170
Closed
353

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$66.5M
2
XOM icon
ExxonMobil
XOM
+$54.9M
3
AAPL icon
Apple
AAPL
+$52.1M
4
HMSY
HMS Holdings Corp.
HMSY
+$48.4M
5
ORCL icon
Oracle
ORCL
+$42.3M

Sector Composition

Rank Sector Weight
1 Technology 15.39%
2 Healthcare 14.66%
3 Consumer Discretionary 14.56%
4 Financials 10.08%
5 Industrials 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NCMI icon
1401
National CineMedia
NCMI
$354M
$106K ﹤0.01%
+2,100
New +$98.5K
ANAC.U
1402
DELISTED
Arctos NorthStar Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-fourth of one redeemable warrant
ANAC.U
$106K ﹤0.01%
10,600
ENDP
1403
DELISTED
Endo International plc
ENDP
$106K ﹤0.01%
+22,600
New +$130K
CECO icon
1404
Ceco Environmental
CECO
$4.42B
$105K ﹤0.01%
+14,600
New +$113K
RYAM icon
1405
Rayonier Advanced Materials
RYAM
$565M
$105K ﹤0.01%
+15,700
New +$128K
VATE icon
1406
INNOVATE Corp
VATE
$114M
$105K ﹤0.01%
2,630
+897
+52% +$36.3K
VIV icon
1407
Telefônica Brasil
VIV
$22.4B
$105K ﹤0.01%
12,358
-33,993
-73% -$285K
COVAU
1408
DELISTED
COVA Acquisition Corp. Unit
COVAU
$105K ﹤0.01%
10,400
IPVA.U
1409
DELISTED
InterPrivate II Acquisition Corp. Units, each consisting of one share of Class A common stock and one-fifth of one redeemable warrant
IPVA.U
$105K ﹤0.01%
10,574
APYX icon
1410
Apyx Medical
APYX
$165M
$103K ﹤0.01%
+10,000
New +$99.1K
MTVA
1411
MetaVia Inc
MTVA
$7.64M
$103K ﹤0.01%
+12
New +$105K
FSRXU
1412
DELISTED
FinServ Acquisition Corp. II Unit
FSRXU
$102K ﹤0.01%
10,200
GGMCU
1413
DELISTED
Glenfarne Merger Corp. Unit
GGMCU
$101K ﹤0.01%
+10,227
New +$102K
AMRX icon
1414
Amneal Pharmaceuticals
AMRX
$5.72B
$99K ﹤0.01%
+19,300
New +$110K
INN
1415
Summit Hotel Properties
INN
$761M
$98K ﹤0.01%
+10,500
New +$104K
QTNT
1416
DELISTED
Quotient Limited Ordinary Shares
QTNT
$97K ﹤0.01%
+668
New +$107K
CALC icon
1417
CalciMedica
CALC
$12M
$96K ﹤0.01%
+1,264
New +$82.9K
ELUT icon
1418
Elutia
ELUT
$41.1M
$96K ﹤0.01%
+10,000
New +$115K
TIPT icon
1419
Tiptree Inc
TIPT
$668M
$96K ﹤0.01%
+10,300
New +$109K
GDX icon
1420
VanEck Gold Miners ETF
GDX
$23B
$93K ﹤0.01%
2,735
-845,882
-100% -$30.9M
APRE icon
1421
Aprea Therapeutics
APRE
$7.83M
$91K ﹤0.01%
+929
New +$85.8K
BH icon
1422
Biglari Holdings Class B
BH
$1.2B
$91K ﹤0.01%
+570
New +$87.7K
GWGH
1423
DELISTED
GWG Holdings, Inc
GWGH
$84K ﹤0.01%
11,801
-2,686
-19% -$18.2K
CLPR
1424
Clipper Realty
CLPR
$46.5M
$82K ﹤0.01%
+11,100
New +$90K
ARAY icon
1425
Accuray
ARAY
$28.4M
$78K ﹤0.01%
+17,300
New +$81K

Similar funds

Ergoteles's Q2 2021 Portfolio in Review

As of Q2 2021, Ergoteles held 1,807 positions worth $4.36B, up 36% from $3.21B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Ergoteles deployed $991M of net new capital in Q2 2021, opening 1,048 new positions and adding to 148 existing holdings. Its largest new stake was Linde: 174,841 shares worth $50.5M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Walt Disney, an estimated $66.5M trimmed.

  • Ergoteles's largest Q2 2021 buy was Linde: 174,841 shares worth $50.5M.
  • Ergoteles added most to PRA Health Sciences, Inc. in Q2 2021, an estimated $160M increase.
  • Ergoteles's biggest Q2 2021 reduction was Walt Disney, cutting an estimated $66.5M.
  • Ergoteles fully exited ExxonMobil in Q2 2021, selling an estimated $54.9M.
  • Ergoteles's ten largest holdings make up 15% of its $4.36B portfolio in Q2 2021.
  • Ergoteles opened 1,048 new positions and closed 353 in Q2 2021.
  • Ergoteles's portfolio value rose 36% quarter-over-quarter to $4.36B.

Based on Ergoteles's 13F filing for Q2 2021, filed 12 Aug 2021.